3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Jump to: navigation, search
3-Aminopyridine-2-carboxaldehyde thiosemicarbazone
200px
IUPAC name 3-aminopyridine-2-carbaldehyde thiosemicarbazone
Identifiers
CAS number 236392-56-6
PubChem 9571836
SMILES C1=CC(=C(N=C1)C=NNC(=S)N)N
Properties
Molecular formula C7H9N5S
Molar mass 195.246 g/mol
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

WikiDoc Resources for 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Articles

Most recent articles on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Most cited articles on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Review articles on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Articles on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Images of 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Photos of 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Podcasts & MP3s on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Videos on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Evidence Based Medicine

Cochrane Collaboration on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Bandolier on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

TRIP on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Clinical Trials

Ongoing Trials on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone at Clinical Trials.gov

Trial results on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Clinical Trials on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

NICE Guidance on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

NHS PRODIGY Guidance

FDA on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

CDC on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Books

Books on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

News

3-Aminopyridine-2-carboxaldehyde thiosemicarbazone in the news

Be alerted to news on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

News trends on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Commentary

Blogs on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Definitions

Definitions of 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Patient Resources / Community

Patient resources on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Discussion groups on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Patient Handouts on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Directions to Hospitals Treating 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Risk calculators and risk factors for 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Healthcare Provider Resources

Symptoms of 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Causes & Risk Factors for 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Diagnostic studies for 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Treatment of 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Continuing Medical Education (CME)

CME Programs on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

International

3-Aminopyridine-2-carboxaldehyde thiosemicarbazone en Espanol

3-Aminopyridine-2-carboxaldehyde thiosemicarbazone en Francais

Business

3-Aminopyridine-2-carboxaldehyde thiosemicarbazone in the Marketplace

Patents on 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

Experimental / Informatics

List of terms related to 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone


Overview

3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, also called Triapine) is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called ribonucleotide reductase inhibitors. 3AP is a potent inhibitor of ribonucleotide reductase, the rate determining enzyme in the supply of deoxynucleotides (DNA building blocks) for DNA synthesis. DNA synthesis is required for cellular proliferation and DNA repair. It is therefore not surprising that it has broad spectrum antitumor activity and synergizes with antitumor drugs that target DNA. It is a very strong iron chelator and in the body it is likely that the iron chelate is the active species that quenches the active site tyrosyl radical required by ribonucleotide reductase for its enzymatic activity. The 3AP iron chelate is redox active and there have been several reports in the literature ascribing this property to some of the biological activities of 3AP. 3AP is a product of the laboratory of Dr Alan C. Sartorelli, a renowned cancer researcher in the Yale University School of Medicine Pharmacology Department. Dr. Sartorelli has a long standing interest in ribonucleotide reductase inhibitors as anticancer agents, and in collaboration with the late Dr. Tai-Shun Lin, and Dr. Mao-Chin Liu, a large number of thiosemicarbazone based ribonucleotide reductase inhibitors were synthesized over several decades. 3AP was chosen, based on the results of studying and the screening these products, as the candidate inhibitor most likely to express activity in the setting of human neoplastic disease. As of 2006, 3AP is being developed by Vion Pharmaceuticals. It has undergone Phase 1 and Phase 2 clinical trials. Vion Pharmaceuticals has also filed several use patents concerning the antiviral and antifungal activity of 3AP.

External links



Linked-in.jpg